Search
Search Results
-
Die Rolle der Systemtherapie bei Lungenmetastasen mit Lymphknotenbefall
Modern systemic therapy with chemotherapy, targeted therapy and immunotherapy has led to a significant improvement in the overall survival in many...
-
Die Rolle der Systemtherapie bei Lungenmetastasen mit Lymphknotenbefall
Modern systemic therapy with chemotherapy, targeted therapy and immunotherapy has led to a significant improvement in the overall survival in many...
-
-
-
Organ- und Fertilitätserhalt beim Zervixkarzinom
Preservation of fertility is important for a significant proportion of patients with cervical cancer. If the disease is diagnosed at an early stage...
-
Adjuvante Mediastinalbestrahlung bei nichtkleinzelligem Lungenkarzinom (pN2)
BackgroundPatients with non-small-cell lung cancer (NSCLC) have a high risk for develo** mediastinal relapse. Although adjuvant chemotherapy is the...
-
-
Indikationen zur selektiven Lymphknotenentfernung bzw. systematischen Lymphknotendissektion axillär, inguinal und iliakal
Lymphadenectomy is a surgical procedure in which lymph nodes are surgically resected. It is usually carried out for oncological surgical treatment of...
-
Was ist gesichert in der Prävention, Diagnostik und Therapie des frühen Mammakarzinoms?
With more than 2.3 million newly diagnosed cases worldwide in 2020, breast cancer is still the most frequent cancer in women and despite improved...
-
Multimodale Therapie des Hochrisiko- und lokal fortgeschrittenen Prostatakarzinoms
Treatment of the high-risk and locally advanced prostate cancer is a challenge in daily practice. At 20–40%, patients with such tumor stages...
-
Diagnostik und Therapie des Vulva- und des Vaginalkarzinoms
Vulvar cancer represents the fourth most common cancer of the female genital region with a standardized morbidity rate of 4.4/100,000 women in...
-
Adjuvante Strahlentherapie des Mammakarzinoms
Adjuvant radiotherapy is an integral part of multimodal therapy for early breast cancer. It contributes to the reduction of local recurrences across...
-
Diagnosestellung eines „cancer of unknown primary“
BackgroundWith an incidence of 1–3% of all malignancies, cancer of unknown primary (CUP) remains a relevant tumor entity. It is defined by...